NEW YORK, Sept. 21, 2017 /PRNewswire/ -- Biotechnology Market Analysis By Application (Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing Bioinformatics), By Technology, And Segment Forecasts, 2014 - 2025
Read the full report: https://www.reportlinker.com/p05108840
The global biotechnology market is expected to reach USD 727.1 billion by 2025, according to a new report by Grand View Research, Inc.
The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent.
These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.
Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as UK and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months' review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.
Further key findings from the report suggest:• Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period• Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market• Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues• North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share• Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years• Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products• Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine• Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza
Read the full report: https://www.reportlinker.com/p05108840
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
https://www.reportlinker.com
__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
Read the full report: https://www.reportlinker.com/p05108840
The global biotechnology market is expected to reach USD 727.1 billion by 2025, according to a new report by Grand View Research, Inc.
Advertisement
The emergence of certain key themes in the biotechnology market is expected to drive growth in this industry to a lucrative extent.
These key themes include regenerative medicine and genetics in diagnostics. Presence of a plethora of companies focusing on the development of regenerative therapies is anticipated to drive sector growth through to 2025. Technological advancements pertaining to the penetration of artificial intelligence in this industry is expected to fuel progress with potential avenues. The companies are engaged in unleashing machine learning in order to understand individual cancer cases, while recommending clinical trials.
Supportive government (and its allied agencies) policies related to synthetic biology is a major growth impacting driver in this sector. Developed economies such as UK and the U.S. are critically monitoring and funding synthetic biology R&D initiatives. For example, in 2010, a six months' review of synthetic biology headed by a panel of expert scientists was enforced by the U.S. President and subsequently conducted a hearing of the Energy and Commerce Committee exclusively concerning synthetic biology.
Further key findings from the report suggest:• Owing to technological advancements and widespread application of this field in various aspects of healthcare, the health segment is expected to exhibit strong progress in the forecast period• Continuous introduction of new biotechnological products to cater to healthcare entities that are involved in diagnosis, prognosis and biopharmaceutical development is estimated to propel the market• Decreasing costs and rise in number of services in this segment are expected to drive segment with lucrative avenues• North American pharmaceutical and biotech companies have experienced great success in the recent years resulting in larger share• Introduction of technologically advanced products and presence of various biotechnology based programs such as the UC Davis Biotechnology Program, the University of California Biotechnology Research and Education Program are attributive to drive the growth of sector in the coming years• Asia Pacific market is anticipated to grow at the most lucrative pace due to changing health care infrastructure in this region which drives the demand for these products• Strong governmental support and recruitment of highly trained Chinese scientists with the support of their administration has made it possible for China to speedily build up capacity in area of regenerative medicine• Key players operating include Gilead, Celgene, Abbott, Novo Nordisk A/S,Novartis AG, Sanofi Aventis, and Lonza
Read the full report: https://www.reportlinker.com/p05108840
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
https://www.reportlinker.com
__________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/biotechnology-market-analysis-by-application-by-technology-and-segment-forecasts-2014---2025-300523615.html
SOURCE Reportlinker
